A
Agilent Technologies, Inc.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$150.84
+0.57%Year over year
Reported trailing growth
- Revenue
- +8.6%
- EBITDA
- +9.6%
- EBIT
- +13.5%
- EPS
- +18.9%
- Free cash flow
- +32.0%
- Operating cash flow
- +7.6%
Forward estimates
Based on analyst estimates
- Revenue
- +6.7%
- EBITDA
- +27.0%
- EPS
- +29.2%
Three-year CAGR
- Revenue
- +0.5%
- EBITDA
- -1.2%
- EBIT
- -2.9%
- Net income
- +1.3%
- EPS
- +3.1%
- Free cash flow
- +4.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jul 1, 2026